Do Wall Street Analysts Like DaVita Stock?

DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services to patients with chronic kidney failure. Valued at $9.3 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. 

Shares of this kidney care giant have underperformed the broader market over the past year. DVA has declined 8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 19.3%. In 2025, DVA stock is down 13.7%, compared to the SPX’s 8.4% rise on a YTD basis.